Effects of Synaptotagmin1 gene knockout on the behavior of mice

doi:10.12047/j.cjap.6233.2022.034

Abstract

Abstract: Objective: To study the effects of Synaptotagmin1 gene knockout (Syt1^+/-) on emotional behavior in mice and explore its possible mechanisms. Methods: Five 8-week-old male Syt1^+/-mice and five wild-type (WT) mice in the same litter were selected. The expressions of Syt1 in 6 mice brain regions of prelimbic cortex (PL), hippocampus (HIP), amygdala (AMY), accumbens nucleus (ACB), caudoputamen (CP) and ventral tegmental area (VTA) were detected by Immunofluorescence staining. Nine 8-week-old male Syt1^+/-mice and ten WT mice were selected as controls. The anxiety-like behaviors of adult Syt1^+/- mice and WT mice were detected by open field test, elevated plus maze test and forced swim test. In addition, five 8-week-old male Syt1^+/-mice and five WT mice were selected to detect the glutamate content in prelimbic cortex, hippocampus and amygdala. Results: Compared with WT mice, the number of Syt1 positive cells in PL, HIP, AMY, ACB, CP and VTA were decreased significantly in Syt1^+/- mice (P＜0.01); Syt1^+/- mice had less total movement distance in open field test (P＜0.01), more preference for peripheral area (P＜0.01) and less desire to explore the central platform (P＜0.01), while Syt1^+/- mice preferred to stay in a closed and safe environment (P＜0.01); the number (P＜0.05) and the time spent in open-arm explorations (P＜0.01) were reduced significantly; the immobile time of Syt1^+/- mice was increased in the forced swim test (P＜0.01). Meanwhile, the concentration of glutamate in the amygdala of Syt1^+/- mice was increased significantly (P＜0.01). Conclusion: Syt1 gene knockout leads to significant anxiety-like behavior in mice, which is deduced that related to the increase of glutamate content in the amygdala.

Key words: Synaptotagmin 1, anxiety, glutamate, mouse

CLC Number:

R338

WU Nan-nan, FENG Rui-rui, ZHANG Yu, LI Guang, CAO Ji-min, YIN Li-tian. Effects of Synaptotagmin1 gene knockout on the behavior of mice[J]. CJAP, 2022, 38(2): 97-101.

References

[1] Giacobbe P, Flint A. Diagnosis and management of anxiety disorders[J]. Continuum, 2018, 24(3): 893-919.
[2] Liu YM, Fan HR, Deng S, et al. Methyleugenol potentiates central amygdala GABAergic inhibition and reduces anxiety[J]. J Pharmacol Exp Ther, 2019, 368(1): 1-10.
[3] Bergink V, van Megen HJ, Westenberg HG. Glutamate and anxiety[J]. Eur Neuropsychopharmacol, 2004, 14(3): 175-183.
[4] Bandelow B. Current and novel psychopharmacological drugs for anxiety disorders[J]. Adv Exp Med Biol, 2020, 1191: 347-365.
[5] Das J. SNARE complex-associated proteins and alcohol[J]. Alcohol Clin Exp Res, 2020, 44(1): 7-18.
[6] Tagliatti E, Bello OD, Mendonca PRF, et al. Synaptotagmin 1 oligomers clamp and regulate different modes of neurotransmitter release[J]. Proc Natl Acad Sci U S A, 2020, 117(7): 3819-3827.
[7] Zhang FX, Sun QJ, Zheng XY, et al. Abnormal expression of synaptophysin, SNAP-25, and synaptotagmin 1 in the hippocampus of kainic acid-exposed rats with behavioral deficits[J]. Cell Mol Neurobiol, 2014, 34(6): 813-824.
[8] Qin S, Young CB, Duan X, et al. Amygdala subregional structure and intrinsic functional connectivity predicts individual differences in anxiety during early childhood[J]. Biol Psychiatry, 2014, 75(11): 892-900.
[9] Boehme S, Ritter V, Tefikow S, et al. Brain activation during anticipatory anxiety in social anxiety disorder[J]. Soc Cogn Affect Neurosci, 2014, 9(9): 1413-1418.
[10] Butler RK, White LC, Frederick-duus D, et al. Comparison of the activation of somatostatin- and neuropeptide Y-containing neuronal populations of the rat amygdala following two different anxiogenic stressors[J]. Exp Neurol, 2012, 238(1): 52-63.
[11] Moreira CM, Masson S, Carvalho MC, et al. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei[J]. Brain Res Bull, 2007, 71(5): 466-474.
[12] Agarwal N, Renshaw PF. Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications[J]. AJNR Am J Neuroradiol, 2012, 33(4): 595-602.
[13] Amir N, Klumpp H, Elias J, et al. Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia[J]. Biol Psychiatry, 2005, 57(9): 975-981.
[14] Öhrfelt A, Brinkmalm A, Dumurgier J, et al. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease[J]. Alzheimers Res Ther, 2016, 8(1): 41-51.
[15] Xiao Z, Gong Y, Wang XF, et al. Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy[J]. J Mol Neurosci, 2009, 38(2):193-200.
[16] Sarkar D. A review of behavioral tests to evaluate different types of anxiety and anti-anxiety effects[J]. Clin Psychopharmacol Neurosci, 2020, 18(3): 341-351.
[17] 王乐, 李碧蓉, 肖志勇, 等. 二氢杨梅素改善慢性社会挫败应激小鼠认知与情感障碍[J]. 中国应用生理学杂志, 2019, 35(6): 496-500.
[18] 李文杰, 杨焕民, 连帅, 等. 大鼠产前母体冷应激对子代自发、探索及焦虑行为的影响[J]. 中国应用生理学杂志, 2019, 35(2): 135-139.
[19] Mei Y, Monteiro P, Zhou Y, et al. Adult restoration of Shank3 expression rescues selective autistic-like phenotypes[J]. Nature, 2016, 530(7591): 481-484.
[20] Natividad L A, Buczynski MW, Herman MA, et al. Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype[J]. Biol Psychiatry, 2017, 82(7): 500-510.